User profiles for Carlo Agostini

Carlo Agostini

Head and Full Professor of Internal Medicine & Clinical Immunology, Padua University
Verified email at unipd.it
Cited by 25130

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus

…, SV de Kreutzenberg, A Tiengo, C Agostini… - Journal of the American …, 2005 - jacc.org
Objectives : We sought to establish whether a reduction in endothelial progenitor cells (EPCs)
has a putative role in peripheral vascular disease (PVD) of type 2 diabetic patients. …

Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency

…, G Spadaro, S Martino, S Donnanno, C Agostini… - Journal of clinical …, 2007 - Springer
Common Variable Immunodeficiency belongs to the group of rare diseases encompassing
antibody deficiency syndromes of highly variable clinical presentation and outcome. The …

Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy

…, A Tiengo, C Agostini… - … , and vascular biology, 2006 - Am Heart Assoc
Objective— Peripheral arterial disease (PAD) is a threatening complication of diabetes. As
endothelial progenitor cells (EPCs) are involved in neovasculogenesis and maintenance of …

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

…, A Soresina, G Spadaro, C Agostini… - Journal of Allergy and …, 2020 - jacionline.org
To the Editor: An epidemic of coronavirus SARS-CoV-2 has become the focus of scientific
attention. 1 The high infectivity of SARS-CoV-2 and rapid rise in the number of patients …

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived …

…, V Frison, S De Kreutzenberg, C Agostini… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE Vasculoprotective endothelial progenitor cells (EPCs) are regulated by stromal-derived
factor-1α (SDF-1α) and are reduced in type 2 diabetes. Because SDF-1α is a …

Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature

GP Fadini, C Agostini, A Avogaro - Atherosclerosis, 2010 - Elsevier
BACKGROUND: Peripheral arterial disease (PAD) is a common cause of disability and
mortality. Up to one third of patients are not susceptible to traditional revascularization and may …

The pathogenesis of pulmonary fibrosis: a moving target

WA Wuyts, C Agostini, KM Antoniou… - European …, 2013 - Eur Respiratory Soc
Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is
characterised by excessive matrix formation leading to destruction of the normal lung architecture …

[HTML][HTML] Coronavirus disease 2019 in patients with inborn errors of immunity: an international study

…, GR Hayman, G Uzel, LO Mendonça, C Agostini… - Journal of Allergy and …, 2021 - Elsevier
Background There is uncertainty about the impact of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …

Sarcoidosis is a Th1/Th17 multisystem disorder

…, GP Fadini, F Calabrese, G Semenzato, C Agostini - Thorax, 2011 - thorax.bmj.com
Background and aims Sarcoidosis is characterised by a compartmentalisation of CD4 + T
helper 1 (Th1) lymphocytes and activated macrophages in involved organs, including the lung. …

[HTML][HTML] Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats

…, M Albiero, I Baesso, A Cabrelle, C Agostini… - Diabetologia, 2006 - Springer
Aims/hypothesis A reduction in the number of endothelial progenitor cells (EPCs) is considered
a plausible cause of increased cardiovascular risk in diabetes mellitus. The aim of this …